HELMD Drive vs. BlueChew: How Do They Compare?

HELMD Drive bottle and sublingual tablet next to a BlueChew Gold pouch and tablet

HELMD Drive and BlueChew's premium Gold product are both sublingual tablets that combine sildenafil (generic Viagra®), tadalafil (generic Cialis®), and apomorphine, three ingredients with clinical evidence for ED. (Note: BlueChew's lower tiers are chewable, single-ingredient PDE5 options.)

Gold adds oxytocin, a pharmaceutical with no clinical evidence for ED7, while Drive keeps a focused three-active formula. In 2026 head-to-head testing, two review publications, The Customer Digest and Protocol Man, both rated Drive first among combination ED treatments5, 6. Here's how they stack up.

Key takeaways

  • Same three actives at the top tier: HELMD Drive and BlueChew Gold are both sublingual tablets combining sildenafil, tadalafil, and apomorphine, at similar dosages8.
  • What about oxytocin? Gold adds oxytocin, which has no clinical evidence for ED7.
  • FDA status: both are compounded and not FDA-approved.
Quick note: This article is for informational purposes only and is not medical advice or an endorsement of one brand over another. Drive is a compounded medication, which is not approved by the FDA. Always talk to a licensed provider about what's right for you. Pricing and products are accurate as of November 20, 2026, where possible.
On this page

Quick comparison

 FeatureHELMD DriveBlueChew Gold
FormatSublingual tablet (dissolves under the tongue)Sublingual tablet (dissolves under the tongue)
PharmaceuticalsSildenafil + tadalafil + apomorphineSildenafil + tadalafil + apomorphine + oxytocin
MechanismsBlood flow (PDE5) + brain arousal pathway (apomorphine)Blood flow (PDE5) + brain arousal pathway (apomorphine). Adds oxytocin, which has no clinical evidence for ED.
Absorption routeSublingual via mouth tissueSublingual via mouth tissue
FDA statusCompounded: not FDA-approvedCompounded: not FDA-approved
AvailabilityU.S. except South CarolinaU.S. except North Dakota
Cost (per tablet, 6 doses / mo, 3 month plan)4$7.67$8.56

The products

HELMD Drive

HELMD Drive is a compounded sublingual tablet combining sildenafil and tadalafil with apomorphine, a dopamine agonist that acts on the brain's arousal pathways. It dissolves under the tongue and comes in two strengths: Drive (sildenafil 65mg, tadalafil 20mg, apomorphine 2mg) and Drive Max (sildenafil 80mg, tadalafil 20mg, apomorphine 3mg). Full detail in How Drive Works.

BlueChew Gold

BlueChew's premium tier, Gold, is a sublingual tablet that combines sildenafil, tadalafil, apomorphine, and oxytocin, offered in three strengths, reported at 70 to 110mg sildenafil, 18 to 22mg tadalafil, 2 to 4mg apomorphine, and 160 to 240 IU of oxytocin8. Gold's upper tiers run above tadalafil's 20mg FDA maximum, with no evidence that going higher adds benefit for ED16. Full detail in our BlueChew Gold review.

HELMD Drive tablet next to a blue BlueChew Gold tablet
Start with a quick online visit

A licensed provider reviews your information and decides whether Drive is appropriate for you.

Get Started

Tablet format

A sublingual tablet dissolves under the tongue, where part of the medication is absorbed directly through the mouth's tissues, bypassing some first-pass metabolism in the liver. That's why sublingual delivery is used when speed of onset matters. For both HELMD Drive and BlueChew Gold, that can mean onset in as little as 15 minutes once the tablet dissolves.

In side-by-side testing, HELMD Drive dissolved in about five minutes; BlueChew Gold took closer to ten, and reviewers found its berry flavor medicinal, with a blue tint left on the tongue5, 6. The tint is a common report among users and reviewers14, 15. We cover the broader comparison in Sublingual vs. chewable vs. swallowed ED meds.

The fourth ingredient

Both HELMD Drive and BlueChew Gold combine two PDE5 inhibitors (sildenafil and tadalafil) with apomorphine, a dopamine agonist that acts centrally on the brain's arousal pathways - a distinct mechanism from the blood-flow effect of the PDE5 inhibitors. That much they share. A sublingual form of apomorphine was approved in Europe specifically for ED17, 18. Apomorphine is used in compounded form in both products; we cover it in Apomorphine for ED.

Sildenafil and tadalafil are first-line ED treatments backed by decades of placebo-controlled trials, though roughly 30 to 40% of men don't get a satisfactory result from a single PDE5 inhibitor alone9.

And pairing sildenafil and tadalafil helps: in a study of 180 men, daily tadalafil plus as-needed sildenafil produced significantly higher erectile function scores than tadalafil alone, with no increase in side effects10.

Apomorphine has shown efficacy in placebo-controlled trials: in pooled trials, sublingual apomorphine produced erections firm enough for intercourse in about half of attempts versus a third on placebo, with a median onset around 18 minutes11, 12.

BlueChew Gold adds a fourth pharmaceutical, oxytocin - a hormone with no established clinical evidence as an ED treatment2. In a double-blind, placebo-controlled trial in men, intranasal oxytocin did not change sexual function measures7, and in a year-long randomized trial in women with sexual dysfunction, it was no better than placebo13.

Each additional pharmaceutical also brings its own side-effect and interaction profile. Without ED evidence, it can be a risk without return.

Availability & cost

HELMD is available across the U.S. except South Carolina. BlueChew states it ships to all U.S. states except North Dakota. Confirm availability for your state at checkout.

On price, compared on the same plan (3 months at 6 doses per month), HELMD Drive comes to $7.67 per tablet and BlueChew Gold comes to $8.56 per tablet4. And Drive is more affordable than Gold at all plan levels4. Neither is typically covered by insurance, though FSA/HSA funds may apply.

Who should choose which

On this comparison, HELMD Drive is the stronger choice: the same sublingual format, the same three evidence-backed actives, no additional risk from a fourth pharmaceutical without evidence for ED7, 13, and a lower per-tablet price on equivalent plans4. Drive also contains no artificial colors or dyes, while Gold's blue dye often leaves a temporary tint on the tongue - reviewers and testers note it consistently5, 6, 14.

As always, a licensed provider should review your history and decide what's appropriate for you.

Is HELMD Drive a good BlueChew alternative?

For men specifically looking at BlueChew alternatives at the Gold tier, HELMD Drive is the closest like-for-like switch: the same three active ingredients in a sublingual tablet, in two strengths, at $7.67 per tablet versus $8.56 on equivalent plans4.

It's cheaper, relies only on ingredients with clinical ED evidence, contains no artificial dyes, and dissolved in about half the time in side-by-side testing5, 6. See how Drive works or check availability and pricing for your state.

Frequently asked questions

HELMD Drive is a sublingual tablet with sildenafil, tadalafil, and apomorphine. BlueChew's premium Gold tier is also sublingual and combines the same three actives plus oxytocin, a pharmaceutical with no clinical evidence for ED7.

Yes - BlueChew Gold includes apomorphine, along with sildenafil, tadalafil, and oxytocin. Within BlueChew's line, only Gold has it. HELMD Drive also uses apomorphine, without the oxytocin.

Oxytocin lacks clinical evidence for ED. BlueChew Gold includes it as a fourth ingredient; Drive does not. It differs from apomorphine, which acts on brain dopamine pathways and is in both.

On the same plan (3 months at 6 doses per month), HELMD Drive comes to $7.67 per tablet and Gold to $8.564. Confirm current pricing with each provider.

Editorial standards. HELMD's content is written to be accurate and current and is reviewed by Board-Certified Urologists on the HELMD Medical Advisory Board. Unless otherwise cited, BlueChew product and pricing details are from BlueChew's own website and third-party reviews; prices and formulations can change, so confirm at checkout. This article is for informational purposes only, is not medical advice, and is not an endorsement of one brand over another. See a mistake? Email support@helmd.com.
Dr. Bilal Chughtai
Reviewed by Dr. Bilal Chughtai, MD
Urologist, functional urology & men's health · HELMD Medical Advisory Board

Dr. Chughtai is a Board-Certified Urologist and the author of 160+ peer-reviewed publications, with fellowship training at Weill Cornell.

Read full bio →

Sources

  1. Hims. Hims vs. BlueChew (BlueChew formats, ingredients, availability except North Dakota, pricing structure). hims.com
  2. Holistic Digest. Best combo ED med 2026: five treatments compared (BlueChew Gold oxytocin, onset, pricing). holisticdigest.com
  3. U.S. Food & Drug Administration. Compounding and the FDA: Questions and Answers. fda.gov
  4. HELMD and BlueChew published plan pricing across monthly and 3-month plans, retrieved October 2026. bluechew.com
  5. The Customer Digest. Best combo ED med 2026: we tested HELMD Drive (taste, dissolve and onset times, per-dose pricing). thecustomerdigest.com
  6. Protocol Man. Best combo ED med 2026: five treatments tested (formulation, onset, handling, per-dose pricing). protocolman.com
  7. Burri A, et al. The acute effects of intranasal oxytocin administration on endocrine and sexual function in males. Psychoneuroendocrinology. 2008;33(5):591-600. Double-blind, placebo-controlled; oxytocin did not alter sexual behaviour measures. pubmed.ncbi.nlm.nih.gov
  8. Innerbody Research. BlueChew Gold Review (Gold tier strengths and per-ingredient dosages). innerbody.com
  9. Dhaliwal A, Gupta M. PDE5 Inhibitors. In: StatPearls [Internet]. StatPearls Publishing; 2023 (first-line status; 30-40% of men without a satisfactory response to a single PDE5 inhibitor). ncbi.nlm.nih.gov
  10. Cui H, Liu B, Song Z, et al. Efficacy and safety of long-term tadalafil 5 mg once daily combined with sildenafil 50 mg as needed at the early stage of treatment for patients with erectile dysfunction. Andrologia. 2015;47(1):20-24. onlinelibrary.wiley.com
  11. Dula E, Keating W, Siami PF, et al; The Apomorphine Study Group. Efficacy and safety of fixed-dose and dose-optimization regimens of sublingual apomorphine versus placebo in men with erectile dysfunction. Urology. 2000;56(1):130-135. pubmed.ncbi.nlm.nih.gov
  12. Stief C, Padley RJ, Perdok RJ, Sleep DJ. Cross-study review of the clinical efficacy of apomorphine SL 2 and 3 mg: pooled data from three placebo-controlled, fixed-dose crossover studies. Eur Urol Suppl. 2002;1(3):12-20. europeanurology.com
  13. Muin DA, Wolzt M, Marculescu R, et al. Effect of long-term intranasal oxytocin on sexual dysfunction in premenopausal and postmenopausal women: a randomized trial. Fertil Steril. 2015;104(3):715-723. Both groups improved; oxytocin was not superior to placebo. pubmed.ncbi.nlm.nih.gov
  14. Innerbody Research. BlueChew MAX Reviews (testers found the blue dye temporarily transferred to the tongue). innerbody.com
  15. Everything Men's Health. BlueChew Gold Review 2026 (reviewers consistently report a temporary blue tint on the tongue). everythingmenshealth.com
  16. U.S. Food & Drug Administration. CIALIS (tadalafil) prescribing information (20 mg maximum approved dose). accessdata.fda.gov
  17. European Medicines Agency. Uprima (apomorphine hydrochloride): EU marketing authorisation for erectile dysfunction, granted May 28, 2001. ema.europa.eu
  18. Altwein JE, Keuler FU. Oral treatment of erectile dysfunction with apomorphine SL. Urol Int. 2001;67(4):257-263. pubmed.ncbi.nlm.nih.gov